Ampio starts phase 1 clinical trial of Ampion for Covid-19 patients

Ampio starts phase 1 clinical trial of Ampion for Covid-19 patients

Published: 8 hours ago By Mateen Dalal

Ampio Pharmaceuticals Inc., the U.S-based biopharmaceutical firm focused on the development of novel therapies aimed at treating common inflammatory conditions, has reportedly commenced recruiting and enrolling patients ....

Eon to use linguistics model to identify IPN and manage lung cancer

Eon, a healthcare technology company, has announced the expansion of its data science models. The model expansion has enabled the identification of incidental pulmonary nodules on MR (magnetic resonance) and X-Ray radiology reports. Eon&rs....

AE Industrial Acquires PCI; Adds New Government Tech Investment

AE Industrial Partners (AEI), a private equity firm specializing in Defense, Aerospace & Government Services, Specialty Industrial markets, and Power Generation announced the acquisition of PCI, a pioneer in providing cybersecurity, clo....

Spectrum Brands buys Armitage to expand its pet solutions portfolio

U.S.-based Fortune 500 company Spectrum Brands Holdings Inc. has reportedly announced the acquisition of Armitage Pet Care Limited for around USD 180 million. Sources close to the matter claimed that the acquisition will allow Spectrum Bra....

Syros unveils Phase 1 clinical trial data of SY-5609; cohort expanded

Syros Pharmaceuticals has announced initial safety, pharmacodynamics (PD) and pharmacokinetics (PK) data from the current dose-escalation portion of Phase 1 clinical trial of SY-5609 in patients with select solid tumors. For the starters, ....

Our Contributors

$row3->name
Mateen Dalal
$row3->name
Akshay Kedari